AngioDynamics, Inc.ANGONASDAQ
LOADING
|||

Analyst Sentiment

Analysts lean bullish — 56% recommend buying.

Consensus Rating
Buy
9 analysts·Limited coverage
56%
Rating Distribution
Strong Buy
00%
Buy
556%
Hold
444%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 73% higher.

Bear Case
$18.00
+73%
Consensus
$18.00
+73%
Bull Case
$18.00
+73%
Price Range9 analysts
Low
Consensus
High
$18.00
$18.00
Current Target
Current Price
$10.42
Upside to Target
$7.58

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Oct 3, 2025Canaccord Genuity
AngioDynamics price target raised to $18 from $17 at Canaccord
Target:$18.00
+53.3%from $11.74
Jul 16, 2025Canaccord Genuity
AngioDynamics price target raised to $17 from $15 at Canaccord
Target:$17.00
+95.0%from $8.72
Oct 4, 2024Canaccord Genuity
AngioDynamics (ANGO) PT Lowered to $12 at Canaccord Genuity
Target:$12.00
+96.7%from $6.10
Sep 20, 2024H.C. Wainwright
H.C. Wainwright Reiterates Buy Rating on AngioDynamics (ANGO)
Target:$14.00
+81.8%from $7.70
Apr 5, 2024Oppenheimer
AngioDynamics upgraded to Outperform from Perform at Oppenheimer
Target:$12.00
+87.5%from $6.40
Jan 6, 2023Raymond James
Raymond James Maintains Strong Buy on AngioDynamics, Lowers Price Target to $22
Target:$22.00
+42.1%from $15.48
Jul 13, 2022Raymond James
Raymond James Maintains Strong Buy on AngioDynamics, Lowers Price Target to $27
Target:$27.00
+34.9%from $20.02